Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
04/09/2014 | CN103709122A Antitumor and antifungal compound for treatment |
04/09/2014 | CN103709093A Combined-ring-containing pleuromutilin antibiotics |
04/09/2014 | CN102781932B Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein |
04/09/2014 | CN102516233B Method for producing voriconazole |
04/09/2014 | CN102432558B Method for synthesizing irbesartan and intermediate thereof |
04/09/2014 | CN102276586B Preparation methods of losartan potassium and preparation thereof |
04/09/2014 | CN102026961B 酰胺化合物 Amide compounds |
04/09/2014 | CN101663283B Quinoxaline compounds and use thereof |
04/08/2014 | US8692000 Phase transfer catalysts |
04/08/2014 | US8691999 Process for the preparation of telmisartan |
04/08/2014 | US8691856 Glucagon receptor antagonists, preparation and therapeutic uses |
04/08/2014 | US8691816 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents |
04/08/2014 | US8691815 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
04/08/2014 | US8691805 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
04/08/2014 | US8691804 Azetidines and cyclobutanes as histamine H3 receptor antagonists |
04/08/2014 | US8691184 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same |
04/08/2014 | CA2563607C 4,5-disubstituted-2-aryl pyrimidines |
04/08/2014 | CA2538315C Matrix metalloproteinase inhibitors |
04/03/2014 | WO2014051165A1 Tetrazolinone compounds and their use as pesticides |
04/03/2014 | WO2014051161A1 Tetrazolinone compounds and their use as pesticides |
04/03/2014 | WO2014051008A1 Deprotection method for tetrazole compound |
04/03/2014 | WO2014051004A1 Material for organic electroluminescent elements, and organic electroluminescent element |
04/03/2014 | WO2014050446A1 Pigment composition, colored curable composition, color filter for solid-state imaging element, method for producing same, solid-state imaging element, pigment dispersion composition, method for producing same, and compound |
04/03/2014 | WO2014050084A1 Novel phenylacetamide compound and pharmaceutical containing same |
04/03/2014 | WO2014049047A1 Substituted sulfonamide compounds |
04/03/2014 | WO2014048532A1 Quinazolinone derivatives as parp inhibitors |
04/03/2014 | WO2014048165A1 Compound as potassium channel modulator |
04/03/2014 | WO2014048072A1 Spiro ring compounds as hepatitis c virus (hcv) inhibitors |
04/03/2014 | WO2013053983A8 Protein kinase inhibitors |
04/03/2014 | US20140094608 Modified carbocyanine dyes and their conjugates |
04/03/2014 | US20140094480 Pro-Neurogenic Compounds |
04/03/2014 | US20140094474 Androgen receptor modulating carboxamides |
04/03/2014 | US20140094471 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
04/03/2014 | US20140094465 Compounds as S-Nitrosoglutathione Reductase Inhibitors |
04/03/2014 | US20140094456 Anti-fibrotic pyridinones |
04/03/2014 | US20140094450 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators |
04/03/2014 | US20140094436 Imidazole compounds that modulate hsp90 activity |
04/03/2014 | US20140093585 Parp inhibitors for the treatment of cipn |
04/03/2014 | US20140093513 Methods of lowering proprotein conversate subtilisin/kexin type 9 (pcsk9) |
04/02/2014 | EP2712863A1 Novel inhibitors of bacterial biofilms and related methods |
04/02/2014 | EP2712861A1 Thioacetate compounds, compositions and methods of use |
04/02/2014 | EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors |
04/02/2014 | EP2712291A1 N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods |
04/02/2014 | CN103702993A Benzamides |
04/02/2014 | CN103702983A Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
04/02/2014 | CN103694276A Dicarbazolyl derivative, preparation method and application of dicarbazolyl derivative, and electroluminescent device |
04/02/2014 | CN103694227A Erlotinib derivative, and preparation method and application thereof |
04/02/2014 | CN103694163A Compounds capable of being adopted as potassium channel modulators |
04/02/2014 | CN102827246B Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof |
04/02/2014 | CN102712623B Hepatitis c virus inhibitors |
04/02/2014 | CN102438996B Histone deacetylase inhibitors with branched structure synthesized through click chemistry |
04/02/2014 | CN102212058B Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor |
04/02/2014 | CN102146215B Pentamethylcyanine fluorescent dye and preparation method and application thereof |
04/02/2014 | CN101939314B Polymorphic forms of a 3-pyrrole substituted 2-indolinone |
04/01/2014 | US8686156 Thiazole derivatives as pesticides |
04/01/2014 | US8686155 Aurora kinase modulators and method of use |
04/01/2014 | US8686145 Process for the preparation of α-acyloxy β-formamido amides |
04/01/2014 | US8686143 Compounds useful as inhibitors of Janus kinases |
04/01/2014 | US8686136 Apoptosis promoters |
04/01/2014 | US8685976 Cell adhesion promoting agent and method of promoting cell adhesion |
04/01/2014 | US8685959 Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists |
04/01/2014 | US8685664 Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease |
04/01/2014 | US8685543 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
04/01/2014 | CA2737299C Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof |
04/01/2014 | CA2619919C Diaminopyrimidines as p2x3 and p2x2/3 modulators |
04/01/2014 | CA2604967C Pyrimidine derivatives and their use as p2y12 receptor antagonists |
03/27/2014 | WO2014046544A1 Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators |
03/27/2014 | WO2014046392A1 Organic compound and electroluminescent element having same |
03/27/2014 | WO2014046352A1 Organic light-emitting compound and organic electroluminescent device using same |
03/27/2014 | WO2014046125A1 Prevention/treatment agent for pulmonary hypertension comprising thrombin receptor antagonist as active component |
03/27/2014 | WO2014045310A1 Pyrimido[5,4-d]pyrimidine or pyrimidine derivatives compounds and uses thereof in the treatment of cancer |
03/27/2014 | WO2014045029A1 2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors |
03/27/2014 | WO2014044755A1 4-(indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer |
03/27/2014 | WO2014044754A1 4-indazolylamino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer |
03/27/2014 | WO2014044738A1 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators |
03/27/2014 | US20140088112 Alkyne benzotriazole derivatives |
03/27/2014 | US20140088106 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
03/27/2014 | US20140088103 (fused ring arylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
03/27/2014 | US20140088102 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
03/27/2014 | US20140088097 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
03/27/2014 | US20140088094 N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE |
03/27/2014 | US20140088071 sGC STIMULATORS |
03/27/2014 | US20140088029 Novel pyrazole derivative |
03/27/2014 | US20140086834 New i-arylpiperazinic ligands of 5-ht7 receptor and use thereof |
03/26/2014 | EP2711365A1 4-Indazolylamino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer |
03/26/2014 | EP2711364A1 4-(Indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer |
03/26/2014 | EP2710007A2 Kinase inhibitors |
03/26/2014 | EP2709997A1 Inhibitors of bruton's tyrosine kinase |
03/26/2014 | EP2709451A1 N-linked lactam m1 receptor positive allosteric modulators |
03/26/2014 | CN103664936A Compounds for treating traumatic brain injury diseases and application thereof |
03/26/2014 | CN103664909A Bicarbazole derivative, preparation method, application and organic light-emitting device |
03/26/2014 | CN103664908A Aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity |
03/26/2014 | CN103664907A Compounds for treating narrow chamber angle and application thereof |
03/26/2014 | CN103664906A 6, 6-dimethyl-6H- benzo [cd] pyrene derivative and application thereof |
03/26/2014 | CN103664905A Tandospirone hydrochloride crystal form II and preparation method thereof |
03/26/2014 | CN103664904A Gamma-secretase inhibitor and use thereof |
03/26/2014 | CN103664903A Benzoazepine compounds and preparation method and application thereof |
03/26/2014 | CN103664902A Imidazoline benzotriazole, and derivative, synthesis technology and application thereof |
03/26/2014 | CN103664901A Novel preparation method for rizatriptan benzoate |
03/26/2014 | CN103664900A Novel method for preparing rizatriptan benzoate |